Cartesian Therapeutics (RNAC) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $722000.0.
- Cartesian Therapeutics' Receivables - Net fell 8504.87% to $722000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $722000.0, marking a year-over-year decrease of 8504.87%. This contributed to the annual value of $872000.0 for FY2024, which is 8514.48% down from last year.
- As of Q3 2025, Cartesian Therapeutics' Receivables - Net stood at $722000.0, which was down 8504.87% from $354000.0 recorded in Q2 2025.
- Cartesian Therapeutics' 5-year Receivables - Net high stood at $32.0 million for Q2 2024, and its period low was $354000.0 during Q2 2025.
- Its 5-year average for Receivables - Net is $7.6 million, with a median of $6.6 million in 2022.
- As far as peak fluctuations go, Cartesian Therapeutics' Receivables - Net surged by 49496.75% in 2024, and later tumbled by 9889.51% in 2025.
- Cartesian Therapeutics' Receivables - Net (Quarter) stood at $9.9 million in 2021, then crashed by 33.47% to $6.6 million in 2022, then decreased by 11.01% to $5.9 million in 2023, then plummeted by 85.14% to $872000.0 in 2024, then decreased by 17.2% to $722000.0 in 2025.
- Its Receivables - Net stands at $722000.0 for Q3 2025, versus $354000.0 for Q2 2025 and $1.8 million for Q1 2025.